Join us on Tuesday, April 26, 2022 from 9:00am-10:30am EDT for a live webinar to learn about the new evidence for improving outcomes for moderately low birthweight infants in limited-resource settings.
During this webinar, study investigators will share the key findings from the Low Birthweight Infant Feeding Exploration (LIFE) study and will engage in an important dialogue on the unique challenges moderately low birthweight infants face and the future implications of this new evidence on their health and survival.
Moderator: Dr. Katherine Semrau, PhD, MPH. Director, BetterBirth Program. Principal Investigator, LIFE Study, Ariadne Labs.
Study results presented by: Dr. Linda Vesel, PhD, MPH. Scientific Lead LIFE Study, BetterBirth Program, Ariadne Labs.
Panelists & LIFE Study Site Principal Investigators:
- Professor Karim Manji, MMED, Fellowship Neonatology, MPH, MBBS. Professor of Pediatrics, Muhimbili University of Health and Allied Sciences. Dar es Salaam, Tanzania.
- Dr. Tisungane Mvalo, MMED, FC Paed, MBBS. Pediatrician, University of North Carolina Project Malawi, based at Kamuzu Central Hospital. Lilongwe, Malawi.
- Dr. Roopa Bellad, MD, DCH, MBBS. Professor, Department of Pediatrics, Jawaharlal Nehru Medical College. Belgaum, India.
A technical representative from Save the Children will share an external perspective on the implications of the LIFE study results within the context of global efforts to improve small and sick newborn care.
Learn more about the LIFE study here. We hope you will join this important discussion alongside members of the global maternal, newborn, and child health community.
About the LIFE Study:
The Low Birthweight Infant Feeding Exploration (LIFE) study was launched in 2019 in collaboration with 14 global partners. This observational study documents current feeding practices, growth patterns, child development, and other health outcomes among more than 1,100 moderately low birthweight infants (1.5kg – <2.5kg) in India, Malawi and Tanzania.
Please reach out to email@example.com if you have any questions.